| Pharmaceutical active ingredients: |
| Nadroparin Calcium |
| Available forms, composition and doses of Fraxiparin: |
| Injectable; Injection; Nadroparin Calcium 1,900 IU / mlInjectable; Injection; Nadroparin Calcium 2,850 IU / mlInjectable; Injection; Nadroparin Calcium 3,800 IU / mlInjectable; Injection; Nadroparin Calcium 5,700 IU / mlInjectable; Injection; Nadroparin Calcium 7,600 IU / mlInjectable; Injection; Nadroparin Calcium 9,500 IU / ml |
| Fraxiparin medical category: |
| Human:Anticoagulants, antiplatelets and fibrinolytics (thrombolytics)Heparins |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B01AB06 - Nadroparin |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisF. Joh. Kwizda |